Kanagawa, Japan

Naoto Fukuyama

This inventor holds 1 USPTO granted patent. Top assignee: Cmic Co., Ltd.. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Naoto Fukuyama. Retrieved from https://idiyas.com/inventor/naoto-fukuyama

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Naoto Fukuyama: Innovator in Nucleic Acid Delivery Systems

Introduction

Naoto Fukuyama is a prominent inventor based in Kanagawa, Japan. He is known for his significant contributions to the field of biotechnology, particularly in the development of nucleic acid delivery systems. His innovative work has the potential to enhance therapeutic applications in medicine.

Latest Patents

Fukuyama holds a patent for a nucleic acid-containing complex. This complex comprises a nucleic acid and a positively charged, water-insoluble biodegradable polymer. The invention is designed to sustain the release of a desired nucleic acid, especially DNA, to a specific site. The complex can be effectively taken up by phagocytes, such as macrophages, allowing for targeted delivery and the exhibition of nucleic acid functions in a specific manner.

Career Highlights

Fukuyama's career is marked by his role at Cmic Co., Ltd., where he has been instrumental in advancing research and development in biotechnology. His innovative approach has led to breakthroughs in how nucleic acids can be delivered within the body, paving the way for new therapeutic strategies.

Collaborations

Fukuyama has collaborated with notable colleagues, including Hidezo Mori and Yasuhiko Tabata. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of biotechnology.

Conclusion

Naoto Fukuyama's work in nucleic acid delivery systems represents a significant advancement in biotechnology. His patented innovations have the potential to transform therapeutic applications, making him a key figure in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…